Bray Capital Advisors’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-950
| Closed | -$5.4K | – | 257 |
|
|
2024
Q3 | $5.4K | Hold |
950
| – | – | ﹤0.01% | 241 |
|
|
2024
Q2 | $4.01K | Hold |
950
| – | – | ﹤0.01% | 240 |
|
|
2024
Q1 | $4.84K | Hold |
950
| – | – | ﹤0.01% | 246 |
|
|
2023
Q4 | $8.85K | Hold |
950
| – | – | ﹤0.01% | 233 |
|
|
2023
Q3 | $6.22K | Hold |
950
| – | – | ﹤0.01% | 238 |
|
|
2023
Q2 | $7.72K | Hold |
950
| – | – | ﹤0.01% | 235 |
|
|
2023
Q1 | $8.14K | Hold |
950
| – | – | ﹤0.01% | 243 |
|
|
2022
Q4 | $8.8K | Hold |
950
| – | – | ﹤0.01% | 243 |
|
|
2022
Q3 | $10K | Hold |
950
| – | – | ﹤0.01% | 256 |
|
|
2022
Q2 | $10K | Hold |
950
| – | – | ﹤0.01% | 246 |
|
|
2022
Q1 | $12K | Buy |
950
+700
| +280% | +$8.84K | ﹤0.01% | 245 |
|
|
2021
Q4 | $4K | Buy |
+250
| New | +$4K | ﹤0.01% | 261 |
|